
Cap 1 N1meψ LbCpf1 mRNA
LbCpf1, derived from Lachnospiraceae bacterium, is another variant of the Cpf1 enzyme. It was discovered subsequent to AsCpf1 and shares similar characteristics in terms of its ability to target specific DNA sequences and induce double-strand breaks for genome editing purposes. LbCpf1, like AsCpf1, offers advantages over the Cas9 enzyme, including recognition of different protospacer adjacent motif (PAM) sequences and the generation of staggered ends after cleavage, facilitating various genome editing applications. This mRNA possesses a Cap1 structure, which is highly efficient in capping. It is fully substituted with N1-methyl-pseudo Uridine to improve expression and decrease immunogenicity. Additionally, the mRNA features a 110A tail in its sequence, resembling a mature mRNA.